Literature DB >> 17445136

Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya.

Heiko Karcher1, Austin Omondi, John Odera, Andrea Kunz, Gundel Harms.   

Abstract

OBJECTIVES: To evaluate risk factors for treatment denial and loss to follow-up in an antiretroviral treatment (ART) cohort in a rural African setting in western Kenya.
METHOD: Sociodemographic and clinical data of patients enrolled in an ART cohort were collected within 18 months of an observational longitudinal study and analysed by logistic and Cox regression models.
RESULTS: Of 159 patients with treatment indication 35 (22%) never started ART. Pregnancy [adjusted odds ratio (AOR) 3.60, 95% confidence interval (CI) 1.10-11.8; P = 0.035] and lower level of education (AOR 3.80, 95% CI 1.14-12.7; P = 0.03) were independently associated with treatment denial. The incidence of total loss of patients under therapy was 43.2 per 100 person years (pys) (mortality rate 19.2 per 100 pys plus drop out rate 24 per 100 pys). Older age [adjusted hazard ratio (AHR) 1.06, 95% CI 1.01-1.12; P = 0.04], AIDS before starting treatment (AHR 5.83, 95% CI 1.15-29.5; P = 0.03) and incomplete adherence to treatment (AHR 1.05, 95% CI 1.03-1.07; P < 0.001) were independent risk factors for death. Incomplete adherence also independently predicted drop out because of other reasons (AHR 1.06, 95% CI 1.04-1.09; P < 0.001).
CONCLUSION: Pregnancy and lower level of education, higher age, advanced AIDS stage and impaired compliance to ART were identified as risk factors for treatment denial and death, respectively. Adequate counselling strategies for patients with these characteristics could help to improve adherence and outcome of treatment programmes in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445136     DOI: 10.1111/j.1365-3156.2007.01830.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  53 in total

1.  Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

Authors:  Ingrid T Katz; Thandekile Essien; Edmore T Marinda; Glenda E Gray; David R Bangsberg; Neil A Martinson; Guy De Bruyn
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

2.  GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda.

Authors:  Mark J Siedner; Alexander Lankowski; Alexander C Tsai; Conrad Muzoora; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; David R Bangsberg
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

Review 3.  Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.

Authors:  Alexander J Lankowski; Mark J Siedner; David R Bangsberg; Alexander C Tsai
Journal:  AIDS Behav       Date:  2014-07

4.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

5.  Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.

Authors:  Elvin H Geng; Mwebesa B Bwana; Winnie Muyindike; David V Glidden; David R Bangsberg; Torsten B Neilands; Ingrid Bernheimer; Nicolas Musinguzi; Constantin T Yiannoutsos; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

6.  The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.

Authors:  Elena Losina; Ingrid V Bassett; Janet Giddy; Senica Chetty; Susan Regan; Rochelle P Walensky; Douglas Ross; Callie A Scott; Lauren M Uhler; Jeffrey N Katz; Helga Holst; Kenneth A Freedberg
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

7.  Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors.

Authors:  Man Charurat; Modupe Oyegunle; Renata Benjamin; Abdulrazaq Habib; Emeka Eze; Prince Ele; Iquo Ibanga; Samuel Ajayi; Maria Eng; Prosanta Mondal; Usman Gebi; Emilia Iwu; Mary-Ann Etiebet; Alash'le Abimiku; Patrick Dakum; John Farley; William Blattner
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

8.  Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.

Authors:  Martin W G Brinkhof; Ben D Spycher; Constantin Yiannoutsos; Ralf Weigel; Robin Wood; Eugène Messou; Andrew Boulle; Matthias Egger; Jonathan A C Sterne
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.

Authors:  Nuala McGrath; Judith R Glynn; Jacqueline Saul; Katharina Kranzer; Andreas Jahn; Frank Mwaungulu; Msenga H C Ngwira; Hazzie Mvula; Fipson Munthali; Venance Mwinuka; Lorren Mwaungulu; Paul E M Fine; Amelia C Crampin
Journal:  BMC Public Health       Date:  2010-10-12       Impact factor: 3.295

10.  Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon.

Authors:  Mathieu Rougemont; Beat E Stoll; Nadia Elia; Peter Ngang
Journal:  AIDS Res Ther       Date:  2009-10-12       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.